BetterLife Pharma Inc. Share Price Other OTC
Equities
BETRF
CA08772P2026
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.33Cr 111.11Cr |
---|---|---|---|---|---|
Net income 2022 | -1.2Cr -100.13Cr | Net income 2023 | -90L -75Cr | EV / Sales 2022 | - |
Net Debt 2022 | 1L 1.16Cr | Net Debt 2023 | 71.69T 59.82L | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/07/17 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26/10/26 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17/07/17 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21/20/21 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05/15/05 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 11TCr | |
+11.38% | 11TCr | |
+0.90% | 2.23TCr | |
-12.64% | 2.22TCr | |
-4.41% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+7.77% | 1.43TCr | |
+37.41% | 1.25TCr |